Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Sani

Showing results (11-20 of 326) with videos related to

Pageof 33
Sort By:
Drugs in R&D|October 23, 2016
Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release FormulationsPaolo Girardi, Roberto Brugnoli, Giovanni Manfredi, et al.
The Psychiatric Clinics of North America|February 4, 2020
Clinical Picture, Temperament, and Personality of Patients with Mixed StatesMario Luciano, Delfina Janiri, Andrea Fiorillo, et al.
Bipolar Disorders|October 4, 2020
Managing Bipolar Disorder patients during COVID-19 outbreakMarianna Mazza, Giuseppe Marano, Luigi Janiri, et al.
Journal of Affective Disorders|February 19, 2021
Transitions: Hagop Souren AkiskalGabriele Sani, Giulio Perugi, Gustavo H Vázquez, et al.
Journal of Clinical Psychopharmacology|March 31, 2018
Long-Term Near-Infrared Photobiomodulation for Anxious Depression Complicated by Takotsubo CardiomyopathyMarco Antonio Caldieraro, Gabriele Sani, Eric Bui, et al.
Psychiatry Research|May 11, 2020
Danger in danger: Interpersonal violence during COVID-19 quarantineMarianna Mazza, Giuseppe Marano, Carlo Lai, et al.
Current Pharmaceutical Design|January 8, 2015
Cerebral white matter injuries following a hypoxic/ischemic insult during the perinatal period: pathophysiology, prognostic factors, and future strategy of treatment approach. A minireviewChristian Zammit, Richard Muscat, Gabriele Sani, et al.
Current Medicinal Chemistry|April 10, 2009
Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoringAlessandro Musenga, Maria Addolorata Saracino, Gabriele Sani, et al.
Journal of Affective Disorders|September 8, 2019
Understanding trauma-induced hippocampal subfield volume changes in the context of age and health. Response to Malhi et alDelfina Janiri, Gabriele Sani, Fabrizio Piras, et al.
CNS & Neurological Disorders Drug Targets|June 2, 2020
Evidence on the New Drug Lumateperone (ITI-007) for Psychiatric and Neurological DisordersMarianna Mazza, Giuseppe Marano, Gianandrea Traversi, et al.
Pageof 33

Showing results (11-20 of 326) with videos related to

Sort By:
Pageof 33
Drugs in R&D|October 23, 2016
Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release FormulationsPaolo Girardi, Roberto Brugnoli, Giovanni Manfredi, et al.
The Psychiatric Clinics of North America|February 4, 2020
Clinical Picture, Temperament, and Personality of Patients with Mixed StatesMario Luciano, Delfina Janiri, Andrea Fiorillo, et al.
Bipolar Disorders|October 4, 2020
Managing Bipolar Disorder patients during COVID-19 outbreakMarianna Mazza, Giuseppe Marano, Luigi Janiri, et al.
Journal of Affective Disorders|February 19, 2021
Transitions: Hagop Souren AkiskalGabriele Sani, Giulio Perugi, Gustavo H Vázquez, et al.
Journal of Clinical Psychopharmacology|March 31, 2018
Long-Term Near-Infrared Photobiomodulation for Anxious Depression Complicated by Takotsubo CardiomyopathyMarco Antonio Caldieraro, Gabriele Sani, Eric Bui, et al.
Psychiatry Research|May 11, 2020
Danger in danger: Interpersonal violence during COVID-19 quarantineMarianna Mazza, Giuseppe Marano, Carlo Lai, et al.
Current Pharmaceutical Design|January 8, 2015
Cerebral white matter injuries following a hypoxic/ischemic insult during the perinatal period: pathophysiology, prognostic factors, and future strategy of treatment approach. A minireviewChristian Zammit, Richard Muscat, Gabriele Sani, et al.
Current Medicinal Chemistry|April 10, 2009
Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoringAlessandro Musenga, Maria Addolorata Saracino, Gabriele Sani, et al.
Journal of Affective Disorders|September 8, 2019
Understanding trauma-induced hippocampal subfield volume changes in the context of age and health. Response to Malhi et alDelfina Janiri, Gabriele Sani, Fabrizio Piras, et al.
CNS & Neurological Disorders Drug Targets|June 2, 2020
Evidence on the New Drug Lumateperone (ITI-007) for Psychiatric and Neurological DisordersMarianna Mazza, Giuseppe Marano, Gianandrea Traversi, et al.
Pageof 33